Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1Phase 2 1Phase 1 1

Status

Recruiting 2Terminated 1Completed 1Active not recruiting 1

Sponsor Class

INDUSTRY 3OTHER 2

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 10Thoracic 7Genitourinary 5CNS 5Breast 4Head & Neck 3Tumor-Agnostic 2Other solid neoplasm 1Lymphoid 1Gynecologic 1

Conditions

Glioblastoma 4Brain Neoplasms 3Neoplasms 2Glioma 2Astrocytoma 2Camurati-Engelmann Syndrome 1

Interventions

Temozolomide 623Radiotherapy 411Bevacizumab 257Magnetic Resonance Spectroscopy 227Cyclophosphamide 179Radiosurgery 163Carboplatin 160Etoposide 132Radiation 129Vincristine 115Irinotecan 115Cisplatin 103Filgrastim 100Specimen Handling 90Nivolumab 88pembrolizumab 84Surgical Procedures, Operative 83Lomustine 83Topotecan 73Doxorubicin 61Melphalan 59Carmustine 57Radiotherapy, Intensity-Modulated 56sargramostim 53Isotretinoin 53Peripheral Blood Stem Cell Transplantation 52Granulocyte Colony-Stimulating Factor 51Chemotherapy, Adjuvant 51Blood Specimen Collection 51Erlotinib Hydrochloride 50

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Drug Delivery Systems × CNS × Clear all
NCT07042620 2026-05-14

A Study to Test a New Fluid to Improve the Quality of Images Obtained by Using Sound Waves (Ultrasound) During Surgery

SonoClear AS

Phase NA Active not recruiting
15 enrolled
CNS

Glioblastoma, Glioma

NCT05733312 2026-01-30

Extracellular Impact of Ultrasound-induced Blood-brain Barrier Disruption

Mayo Clinic

Phase NA Recruiting
6 enrolled
CNS

Brain Neoplasms

NCT07141732 2025-09-16

Combined Treatment of Patients With Newly Diagnosed Glioblastoma Using the Xoft® Axxent® Electronic Brachytherapy (eBx®) System for Intraoperative Balloon Electronic Brachytherapy

Joint Stock Company European Medical Centre

Phase 1 Recruiting
15 enrolled
CNS

Glioblastoma

NCT00761280 2014-11-14

SAPPHIRE

Isarna Therapeutics GmbH

Phase 3 Terminated
27 enrolled 28 charts
CNS

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Neoplasms

NCT00431561 2013-12-03

Phase IIb Clinical Trial With TGF-β2 Antisense Compound AP 12009 for Recurrent or Refractory High-grade Glioma

Isarna Therapeutics GmbH

Phase 2 Completed
141 enrolled
CNS

Astrocytoma, Brain Neoplasms, Camurati-Engelmann Syndrome, Glioblastoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡